Increased tyrosine phosphorylation of platelet proteins including pp125FAK suggests endogenous activation and aggregation in pulmonary hypertension

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 4, 2005, Pages 411-415

  Maeda, Nair Y ^a,b   Bydlowski, Sergio P ^a   Lopes, Antonio A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Divisão de Pesquisa e Biologia Molecular   (Brazil)

Author keywords

Platelets; Pulmonary hypertension; Signal transduction; Thrombosis; Tyrosine kinases

Indexed keywords

ALPHA2B BETA3 INTEGRIN; FOCAL ADHESION KINASE; INTEGRIN; PHOSPHOTYROSINE; PLATELET PROTEIN 120; PLATELET PROTEIN 60C SRC; PROTEIN; PROTEIN KINASE P60; PROTEIN PP125FAK; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ADOLESCENT; ADULT; BLOOD PLATELETS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PHOSPHORYLATION; PHOSPHOTYROSINE; PLATELET ACTIVATION; PLATELET AGGREGATION;

EID: 27544454099     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100407     Document Type: Article

References (18)

1. Clark EA, Brugge JS. Tyrosine phosphorylation. In: Watson SP, Authi KS, eds. Platelets-A Practical Approach. London: Oxford University Press, 1996, p. 199.
2. c-src: Implications for regulation. Science 1986;231:1431.
3. Clark EA, Shattil SJ, Ginsberg MH, et al. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin αIIb/β3. J Biol Chem 1994;269:28859.
4. Law DA, Nannizzi-Alaimo L, Phillips DR. Outside-in integrin signal transduction. (GPIIbIIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 1996;271:10811.
5. FAK in platelets. J Cell Biol 1992;119:905.
6. FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem 1994;269:14738.
7. Lopes AA, Maeda NY, Almeida A, et al. Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology 1993;9:701.
8. Schulman LL, Grosman BA, Owen J. Platelet activation and fibrinopeptide formation in pulmonary hypertension. Chest 1993;104:1690.
9. Mustard JF, Perry W, Ardlie NG, et al. Preparation of suspensions of washed platelets from human. Br J Haematol 1972;22:193.
10. Sastry KS, Burridge K. Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 2000;261:25.
11. c-src family of protein-tyrosine kinases. Int J Biochem Cell Biol 1995;27:551.
12. Ji P, Haimovich B. Integrin αIIbβ3-mediated pp125FAK phosphorylation and platelet spreading on fibrinogen are regulated by PI3-kinase. Biochim Biophys Acta 1999;1448:543.
13. Jackson SP, Schoenwalder SM, Yuan Y, et al. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 1996;76:640.
14. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: The platelet paradigm. Blood 1998;91:2645.
15. Hervé P, Drouet L, Dosquet C, et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: Role of serotonin. Am J Med 1990;89:117.
16. Hervé P, Launay JM, Scrobohaci ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249.
17. Caramuru LH, Soares RP, Maeda NY, et al. Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension. Clin Appl Thromb Hemost 2003;9:251.
18. Kéreveur A, Callebert J, Humbert M, et al. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscl Thromb Vasc Biol 2000;20:2233.